Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars B Nielsen

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of the American Society of Nephrology : JASN|September 30, 2003
Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient miceSusanne Bro, Jacob F Bentzon, Erling Falk, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2010
The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- miceTanja X Pedersen, Christoph J Binder, Gunilla N Fredrikson, et al.
Diabetes/Metabolism Research and Reviews|June 14, 2008
Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetesMarie L S Lindegaard, Eva M M Svarrer, Peter Damm, et al.
The American Journal of Pathology|March 17, 2018
Imiquimod-Induced Psoriasis-Like Skin Lesions Do Not Accelerate Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceMarie Madsen, Peter R Hansen, Lars B Nielsen, et al.
International Journal of Molecular Sciences|February 27, 2013
The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosisBas W C Arkensteijn, Jimmy F P Berbée, Patrick C N Rensen, et al.
Atherosclerosis|March 29, 2008
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic miceSusanne Bro, Allan Flyvbjerg, Christoph J Binder, et al.
Atherosclerosis|May 21, 2008
Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient miceTanja X Pedersen, Susanne Bro, Mikkel H Andersen, et al.
Clinical Chemistry|September 24, 2005
Increased plasma pro-B-type natriuretic peptide in infants of women with type 1 diabetesKaren G Halse, Marie L S Lindegaard, Jens P Goetze, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 16, 2018
Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphateAdelina Yafasova, Camilla M Mandrup, Jon Egelund, et al.
Experimental Physiology|July 5, 2011
Endothelial function after 10 days of bed rest in individuals at risk for type 2 diabetes and cardiovascular diseaseMette P Sonne, Lise Højbjerre, Amra C Alibegovic, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of the American Society of Nephrology : JASN|September 30, 2003
Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient miceSusanne Bro, Jacob F Bentzon, Erling Falk, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 19, 2010
The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- miceTanja X Pedersen, Christoph J Binder, Gunilla N Fredrikson, et al.
Diabetes/Metabolism Research and Reviews|June 14, 2008
Increased LDL cholesterol and CRP in infants of mothers with type 1 diabetesMarie L S Lindegaard, Eva M M Svarrer, Peter Damm, et al.
The American Journal of Pathology|March 17, 2018
Imiquimod-Induced Psoriasis-Like Skin Lesions Do Not Accelerate Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceMarie Madsen, Peter R Hansen, Lars B Nielsen, et al.
International Journal of Molecular Sciences|February 27, 2013
The apolipoprotein m-sphingosine-1-phosphate axis: biological relevance in lipoprotein metabolism, lipid disorders and atherosclerosisBas W C Arkensteijn, Jimmy F P Berbée, Patrick C N Rensen, et al.
Atherosclerosis|March 29, 2008
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic miceSusanne Bro, Allan Flyvbjerg, Christoph J Binder, et al.
Atherosclerosis|May 21, 2008
Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient miceTanja X Pedersen, Susanne Bro, Mikkel H Andersen, et al.
Clinical Chemistry|September 24, 2005
Increased plasma pro-B-type natriuretic peptide in infants of women with type 1 diabetesKaren G Halse, Marie L S Lindegaard, Jens P Goetze, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 16, 2018
Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphateAdelina Yafasova, Camilla M Mandrup, Jon Egelund, et al.
Experimental Physiology|July 5, 2011
Endothelial function after 10 days of bed rest in individuals at risk for type 2 diabetes and cardiovascular diseaseMette P Sonne, Lise Højbjerre, Amra C Alibegovic, et al.
Pageof 7